Should We Fear Resistance From Tenofovir/Emtricitabine Preexposure Prophylaxis?

Current Opinion in HIV and AIDS - United States
doi 10.1097/coh.0000000000000209
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)